Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

AstraZeneca (NASDAQ:AZN) said detailed results from a late stage outpatient treatment trial showed Evusheld provided statistically significant protection against progression to severe COVID-19 or ...

A medication is available to prevent COVID in people with compromised immune systems but many of those eligible in New Jersey don’t know about it and haven’t received it. The medication, Evusheld, ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently withdrew its emergency use authorization for Evusheld, a combination monoclonal antibody ...

Health workers are preparing for a possible "tripledemic" of flu, COVID-19, and RSV this winter. Here's how to tell the difference. Shutterstock The US Food and Drug Administration on Thursday halted ...

Evusheld is not being recommended for immunocompromised people to protect against COVID-19 in the UK, despite a long running campaign calling for it to be made available on the NHS. The National ...

In the midst of the Covid-19 surge during the winter of 2021, the Pittsburgh-based UPMC health system received 450 doses of Evusheld — a scarce antibody cocktail being used at the time to prevent ...

The Food and Drug Administration has withdrawn emergency use authorization for AstraZeneca’s Covid-19 antibody cocktail Evusheld as the treatment is not expected to neutralize the currently dominant ...

The CDC urged people with weak immune systems to wear masks and practice social distancing after Covid subvariants knocked out Evusheld. Evusheld was a key antibody treatment taken by ...